Literature DB >> 18614783

Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation.

Denice M Hodgson-Zingman1, Margaret L Karst, Leonid V Zingman, Denise M Heublein, Dawood Darbar, Kathleen J Herron, Jeffrey D Ballew, Mariza de Andrade, John C Burnett, Timothy M Olson.   

Abstract

Atrial fibrillation is a common arrhythmia that is hereditary in a small subgroup of patients. In a family with 11 clinically affected members, we mapped an atrial fibrillation locus to chromosome 1p36-p35 and identified a heterozygous frameshift mutation in the gene encoding atrial natriuretic peptide. Circulating chimeric atrial natriuretic peptide (ANP) was detected in high concentration in subjects with the mutation, and shortened atrial action potentials were seen in an isolated heart model, creating a possible substrate for atrial fibrillation. This report implicates perturbation of the atrial natriuretic peptide-cyclic guanosine monophosphate (cGMP) pathway in cardiac electrical instability. 2008 Massachusetts Medical Society

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18614783      PMCID: PMC2518320          DOI: 10.1056/NEJMoa0706300

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  23 in total

1.  Natriuretic peptide receptors and neutral endopeptidase in mediating the renal actions of a new therapeutic synthetic natriuretic peptide dendroaspis natriuretic peptide.

Authors:  Horng H Chen; John G Lainchbury; John C Burnett
Journal:  J Am Coll Cardiol       Date:  2002-09-18       Impact factor: 24.094

2.  Effects of atrionatriuretic factor on Ca2+ current and Cai-independent transient outward K+ current in human atrial cells.

Authors:  B Le Grand; E Deroubaix; J P Couétil; E Coraboeuf
Journal:  Pflugers Arch       Date:  1992-08       Impact factor: 3.657

Review 3.  Genes and atrial fibrillation: a new look at an old problem.

Authors:  Diane Fatkin; Robyn Otway; Jamie I Vandenberg
Journal:  Circulation       Date:  2007-08-14       Impact factor: 29.690

4.  Atrionatriuretic peptide transforms cardiac sodium channels into calcium-conducting channels.

Authors:  L A Sorbera; M Morad
Journal:  Science       Date:  1990-02-23       Impact factor: 47.728

5.  Electrophysiological effects of atrial natriuretic peptide on the cardiac conduction system in man.

Authors:  I Crozier; A M Richards; S G Foy; H Ikram
Journal:  Pacing Clin Electrophysiol       Date:  1993-04       Impact factor: 1.976

6.  Lifetime risk for development of atrial fibrillation: the Framingham Heart Study.

Authors:  Donald M Lloyd-Jones; Thomas J Wang; Eric P Leip; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Ralph B D'Agostino; Joseph M Massaro; Alexa Beiser; Philip A Wolf; Emelia J Benjamin
Journal:  Circulation       Date:  2004-08-16       Impact factor: 29.690

7.  Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring.

Authors:  Caroline S Fox; Helen Parise; Ralph B D'Agostino; Donald M Lloyd-Jones; Ramachandran S Vasan; Thomas J Wang; Daniel Levy; Philip A Wolf; Emelia J Benjamin
Journal:  JAMA       Date:  2004-06-16       Impact factor: 56.272

8.  Atrial natriuretic peptide modulates the hyperpolarization-activated current (If) in human atrial myocytes.

Authors:  Giuseppe Lonardo; Elisabetta Cerbai; Simona Casini; Gabriele Giunti; Massimo Bonacchi; Francesco Battaglia; Brenno Fiorani; Pier Luigi Stefano; Guido Sani; Alessandro Mugelli
Journal:  Cardiovasc Res       Date:  2004-08-15       Impact factor: 10.787

9.  Atrial natriuretic peptide elevation in congestive heart failure in the human.

Authors:  J C Burnett; P C Kao; D C Hu; D W Heser; D Heublein; J P Granger; T J Opgenorth; G S Reeder
Journal:  Science       Date:  1986-03-07       Impact factor: 47.728

10.  Familial atrial fibrillation is a genetically heterogeneous disorder.

Authors:  Dawood Darbar; Kathleen J Herron; Jeffrey D Ballew; Arshad Jahangir; Bernard J Gersh; Win-K Shen; Stephen C Hammill; Douglas L Packer; Timothy M Olson
Journal:  J Am Coll Cardiol       Date:  2003-06-18       Impact factor: 24.094

View more
  125 in total

1.  Pitx2 prevents susceptibility to atrial arrhythmias by inhibiting left-sided pacemaker specification.

Authors:  Jun Wang; Elzbieta Klysik; Subeena Sood; Randy L Johnson; Xander H T Wehrens; James F Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

2.  Symptomatic response to antiarrhythmic drug therapy is modulated by a common single nucleotide polymorphism in atrial fibrillation.

Authors:  Babar Parvez; Joseph Vaglio; Shane Rowan; Raafia Muhammad; Gayle Kucera; Tanya Stubblefield; Shannon Carter; Dan Roden; Dawood Darbar
Journal:  J Am Coll Cardiol       Date:  2012-06-20       Impact factor: 24.094

3.  KCNA5 gene polymorphism associate with idiopathic atrial fibrillation.

Authors:  Li Tian; Gang Liu; Le Wang; Mingqi Zheng; Yongjun Li
Journal:  Int J Clin Exp Med       Date:  2015-06-15

Review 4.  Genetics of Atrial Fibrillation in 2020: GWAS, Genome Sequencing, Polygenic Risk, and Beyond.

Authors:  Carolina Roselli; Michiel Rienstra; Patrick T Ellinor
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

5.  European ancestry as a risk factor for atrial fibrillation in African Americans.

Authors:  Gregory M Marcus; Alvaro Alonso; Carmen A Peralta; Guillaume Lettre; Eric Vittinghoff; Steven A Lubitz; Ervin R Fox; Yamini S Levitzky; Reena Mehra; Kathleen F Kerr; Rajat Deo; Nona Sotoodehnia; Meggie Akylbekova; Patrick T Ellinor; Dina N Paltoo; Elsayed Z Soliman; Emelia J Benjamin; Susan R Heckbert
Journal:  Circulation       Date:  2010-11-16       Impact factor: 29.690

6.  Insulin-degrading enzyme modulates the natriuretic peptide-mediated signaling response.

Authors:  Luis A Ralat; Qing Guo; Min Ren; Todd Funke; Deborah M Dickey; Lincoln R Potter; Wei-Jen Tang
Journal:  J Biol Chem       Date:  2010-11-22       Impact factor: 5.157

7.  Corin, atrial natriuretic peptide and hypertension.

Authors:  Yiqing Zhou; Jingjing Jiang; Yujie Cui; Qingyu Wu
Journal:  Nephrol Dial Transplant       Date:  2009-01-07       Impact factor: 5.992

8.  Lamin A mutation impairs interaction with nucleoporin NUP155 and disrupts nucleocytoplasmic transport in atrial fibrillation.

Authors:  Meng Han; Miao Zhao; Chen Cheng; Yuan Huang; Shengna Han; Wenjuan Li; Xin Tu; Xuan Luo; Xiaoling Yu; Yinan Liu; Qiuyun Chen; Xiang Ren; Qing Kenneth Wang; Tie Ke
Journal:  Hum Mutat       Date:  2018-12-08       Impact factor: 4.878

Review 9.  A contemporary review on the genetic basis of atrial fibrillation.

Authors:  Jason D Roberts; Michael H Gollob
Journal:  Methodist Debakey Cardiovasc J       Date:  2014 Jan-Mar

10.  Molecular basis of selective atrial fibrosis due to overexpression of transforming growth factor-β1.

Authors:  Dolkun Rahmutula; Gregory M Marcus; Emily E Wilson; Chun-Hua Ding; Yuanyuan Xiao; Agnes C Paquet; Rebecca Barbeau; Andrea J Barczak; David J Erle; Jeffrey E Olgin
Journal:  Cardiovasc Res       Date:  2013-04-23       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.